MDD US Operations, LLC Sustainability Profile
MDD US Operations, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States, with significant operations across various regions. Founded in 2018, the company has quickly established itself as a leader in the development and distribution of innovative medical products, particularly in the realm of specialty pharmaceuticals. MDD US Operations focuses on delivering high-quality, patient-centric solutions that address unmet medical needs. Their core offerings include a range of prescription medications and healthcare services, distinguished by their commitment to safety and efficacy. The company has achieved notable milestones, including strategic partnerships that enhance its market presence and product accessibility. With a strong emphasis on research and development, MDD US Operations continues to solidify its position in the competitive landscape, striving to improve patient outcomes and contribute to the advancement of healthcare.
DitchCarbon Score
How does MDD US Operations, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MDD US Operations, LLC's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MDD US Operations, LLC's reported carbon emissions
MDD US Operations, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Supernus Pharmaceuticals, Inc., which may influence its climate commitments and reporting practices. While MDD US Operations, LLC does not have documented reduction targets or specific climate pledges, it is important to note that its parent company, Supernus Pharmaceuticals, Inc., may have established initiatives that could impact MDD's operational strategies. However, details regarding these initiatives or any specific emissions reduction targets have not been provided. As a subsidiary, MDD US Operations, LLC's climate commitments may align with broader corporate sustainability goals set by Supernus Pharmaceuticals, Inc., but without explicit data or targets, the company's individual climate impact remains unclear.
How Carbon Intensive is MDD US Operations, LLC's Industry?
How Carbon Intensive is MDD US Operations, LLC's Location?
MDD US Operations, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MDD US Operations, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
